Results 1 to 5 of 9
Most popular |Most recent

Is International Drug Pricing Suddenly at Our Doorstep? Seven Take-Aways from the Interim Final Rule

OECD, USA - November 23 2020 On Friday, November 20, the Centers for Medicare & Medicaid Services (CMS) released an interim final rule (IFR) with comment period that implements a…

Douglas Hallward-Driemeier, Margaux J. Hall, Meredythe Ryan, Stephanie A. Webster, Thomas N. Bulleit.

International Reference Pricing for Medicare Drugs: New Lease on Life or Least Likely to Succeed?

OECD, USA - September 16 2020 On Sunday, September 13, 2020, President Donald Trump issued a long-anticipated Executive Order on international reference drug pricing (the "EO")…

Caroline Himamshu, Deborah Kantar Gardner, Josiah Irvin, Thomas N. Bulleit.

Drug Pricing Reforms and Value-Based Pricing: Future and Current Implications for Drug Companies - Part 1: Federal Legislative and Executive Actions

USA - August 4 2020 On July 24, President Trump announced a series of executive orders on prescription drug prices, making no current changes in law, but ordering…

Elana Bengualid Harary, Thomas N. Bulleit.

Proposed Rule Seeks to Promote Adoption of Value-Based Purchasing Arrangements

USA - July 1 2020 On June 17, 2020, the Centers for Medicare & Medicaid Services (CMS) issued a proposed rule that, if finalized, would modify significantly the…

Joanna Hwang, Thomas N. Bulleit.

HHS Highlights Federal Telehealth Initiatives in Response to COVID-19

USA - June 11 2020 On June 5, 2020, the U.S. Department of Health and Human Services ("HHS") released a Fact Sheet regarding its efforts to address COVID-19's disparate…

Thomas N. Bulleit.